arrow
返回
M

Mehmet Bilici

Ataturk University

22H指数
120论文数
2.6K被引数
收录论文 14
发表时间
Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score
err2026-01-08
err0
errOAAI
errMehmet Emin Buyukbayram; Zekeriya Hannarici; Aykut Turhan; Alperen Akansel Çağlar; Pınar Çoban Eşdur; Mehmet Bilici; Salim Başol Tekin; Canan Dinar Ayman
err分享
err收藏
err分享
err收藏
Bridging East and West: Real-World Clinicogenomic Landscape of Metastatic NSCLC in Türkiye连接东西方:土耳其转移性非小细胞肺癌的真实世界临床基因组学景观
err2025-12-03
err0
errOAAI
errKübra Canaslan; Emre Eken; Mehmet Bilici; Fahriye Merve Balcıoğlu; Banu Öztürk; Mehmet Çakmak; Öznur Bal; Görkem Turhan; Feyyaz Özdemir; Hayati Arvas; Zuhat Urakçı; Ebru Çiçek; Zeynep Hande Turna; Aziz Karaoğlu
err分享
err收藏
Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+advanced, unresectable or metastatic G/GEJ adenocarcinomaKEYNOTE-811研究的III期最终总生存数据,该研究评估了帕博利珠单抗联合曲妥珠单抗和化疗治疗HER2阳性、不可切除或转移性胃/胃食管结合部腺癌。
err2024-12-01
err0
PREAI
errRha, S. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J-P.; Weber, P. E. Yanez; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y. V.; Bilici, M.; Chung, H. C.; Shitara, K.; Mahave, M.; van Cutsem, E.; Tabernero, J.; Xu, L.; Sharan, K. P.; Bhagia, P.; Janjigian, Y. Y.
err分享
err收藏
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker
err2024-07-01
err2
errOAAI
errBuyukbayram, Mehmet Emin; Hannarici, Zekeriya; Duzkopru, Yakup; Turhan, Aykut; Caglar, Alperen Akansel; Esdur, Pinar Coban; Bilici, Mehmet; Tekin, Salim Basol; Yazilitas, Dogan
err分享
err收藏
A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)
err2024-05-23
err1
errOAAI
errBuyukbayram, Mehmet Emin; Hannarici, Zekeriya; Turhan, Aykut; Caglar, Alperen Akansel; Esdur, Pinar coban; Bilici, Mehmet; Tekin, Salim Basol; Erdemci, Burak
err分享
err收藏
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trialPembrolizumab联合曲妥珠单抗和化疗治疗HER2-positive胃或胃食管交界处腺癌: 来自3期KEYNOTE-811随机安慰剂对照试验的中期分析
errLANCET
IF88.5
err2023-12-01
err120
PREAI
errJanjigian, Yelena Y.; Kawazoe, Akihito; Bai, Yuxian; Xu, Jianming; Lonardi, Sara; Metges, Jean Phillipe; Yanez, Patricio; Wyrwicz, Lucjan S.; Shen, Lin; Ostapenko, Yuriy; Bilici, Mehmet; Chung, Hyun Cheol; Shitara, Kohei; Qin, Shu-Kui; Van Cutsem, Eric; Tabernero, Josep; Li, Kan; Shih, Chie-Schin; Bhagia, Pooja; Rha, Sun Young
err分享
err收藏
err分享
err收藏
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
err2023-10-01
err33
errOAAI
errJanjigian, Y. Y.; Al-Batran, S-E.; Wainberg, Z. A.; Van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Oh, D. Y.; Omori, T.; Moehler, M.; Garrido, M.; Oliveira, S. Cunha Sousa; Liberman, M.; Oliden, V. Castro; Bilici, M.; Kurland, J. F.; Xynos, I.; Mann, H.; Tabernero, J.
err分享
err收藏
Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study
err2023-10-01
err3
errOAAI
errJanjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J-P.; Weber, P. E. Yanez; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y. V.; Bilici, M.; Chung, H. C.; Shitara, K.; Qin, S.; Van Cutsem, E.; Tabernero, J.; Li, K.; Shih, C-S.; Bhagia, P.; Rha, S. Y.
err分享
err收藏
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer
err2023-03-09
err5
PREAI
errHannarici, Zekeriya; Yilmaz, Ali; Buyukbayram, Mehmet Emin; Turhan, Aykut; Caglar, Alperen Akansel; Bilici, Mehmet; Tekin, Salim Basol
err分享
err收藏
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib
err2021-08-25
err13
PREAI
errYilmaz, Ali; Simsek, Melih; Hannarici, Zekeriya; Buyukbayram, Mehmet E.; Bilici, Mehmet; Tekin, Salim B.
err分享
err收藏
Efficacy and tolerability of first-line chemotherapy in elderly patients ( age ≥70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
err2016-10-01
err0
errOAAI
errAldemir, M. N.; Turkeli, M.; Hacioglu, B.; Sakin, A.; Yaman, E.; Coban, E.; Koca, D.; Karaca, M.; Simsek, M.; Bahceci, A.; Sen, E.; Eren, T.; Aliustaoglu, B. O.; Sakalar, T.; Kalkan, N. O.; Aktas, G.; Bilici, M.; Turhal, S.; Benekli, M.; Tekin, S. B.
err分享
err收藏